Browse result page of THPdb

The total number entries retrieved from this search are 28

ID	ThPPID	Name	Peptide Sequence	Length	Functional Classification	Disease	Brand	Company	Physical Appearance	Route of Administartion	Category	Target
ID1385	ThPPIDTh1061	NameTrastuzumab	Peptide SequenceLight chain 1: DIQMT Full view	Length1364	Functional ClassificationIIa	DiseaseCancer	BrandHerceptin	CompanyGenentech	Physical AppearanceSterile, white to pale yellow, preservative-free lyophilized powder	Route of Administartion Intravenous administration	CategoryAntineoplastic Agents	TargetInsulin receptor,Insulin-like growth factor 1 receptor,Insulin-degrading enzyme,HLA class II histocompatibility antigen, DQ alpha 2 chain,HLA class II histocompatibility antigen, DQ beta 1 chain,Retinoblastoma-associated protein,Cathepsin D,Carboxypeptidase E,Neuroendocrine convertase 2,Neuroendocrine convertase 1,Protein NOV homolog,Low-density lipoprotein receptor-related protein 2,Insulin-like growth factor-binding protein 7,Synaptotagmin-like protein 4
ID1412	ThPPIDTh1068	NameTositumomab	Peptide SequenceHeavy Chain 1: QAYLQ Full view	Length1351	Functional ClassificationIIb	DiseaseCancer	BrandBexxar	CompanyGalaxo Smith Kline	Physical AppearanceSterile, pyrogen-free, clear to opalescent, colorless to slightly yellow, preservative-free solutionÂÂÂ	Route of AdministartionIntravenous(IV) administration	CategoryN.A.	TargetBacterial outer membrane,Lipoteichoic acid synthesis
ID1419	ThPPIDTh1070	NameBotulinum Toxin Type A	Peptide SequenceMPFVNKQFNYKDPVNGVDIA Full view	Length1296	Functional ClassificationIc	DiseaseNeurological Disorder	BrandBOTOXÂÂÂ	CompanyAllergan	Physical AppearanceSterile, vacuum-dried purified botulinum toxin type A, produced from fermentation of Hall strainClostridium botulinum type A	Route of AdministartionIntramuscular, intradetrusor and intradermal use	CategoryNeuromuscular Blocking Agents, Anti-Wrinkle Agents and Antidystonic Agents	TargetGrowth hormone receptor
ID1420	ThPPIDTh1070	NameBotulinum Toxin Type A	Peptide SequenceMPFVNKQFNYKDPVNGVDIA Full view	Length1296	Functional ClassificationIc	DiseaseNeurological Disorder	BrandDysport	CompanyIpsen Pharmaceuticals	Physical AppearanceSterile vial for reconstitution	Route of AdministartionIntramuscular Injection	CategoryNeuromuscular Blocking Agents, Anti-Wrinkle Agents and Antidystonic Agents	TargetGrowth hormone receptor
ID1421	ThPPIDTh1070	NameBotulinum Toxin Type A	Peptide SequenceMPFVNKQFNYKDPVNGVDIA Full view	Length1296	Functional ClassificationIc	DiseaseNeurological Disorder	BrandXeomin	CompanyMERZ AESTHETICS	Physical AppearanceSterile white to off-white lyophilized powder after reconstitution with preservative-free 0.9% Saline for Injection.	Route of AdministartionIntramuscular Injection	CategoryNeuromuscular Blocking Agents, Anti-Wrinkle Agents and Antidystonic Agents	TargetGrowth hormone receptor
ID1422	ThPPIDTh1071	NamePancrelipase	Peptide SequencePancreatic alpha amy Full view	Length1206	Functional ClassificationIa	DiseaseMetabolic/genetic/	BrandPancrecarb	CompanyDigestive care US, Inc.	Physical AppearanceDelayed-Release Capsules, Buffered and Enteric-Coated Microspheres.	Route of AdministartionOral route	CategoryGastrointestinal Agents and Enzyme Replacement Agents	TargetSynaptosomal-associated protein 25,Rho-related GTP-binding protein RhoB, Dietary fat,Dietary protein,Dietary starch
ID1423	ThPPIDTh1071	NamePancrelipase	Peptide SequencePancreatic alpha amy Full view	Length1206	Functional ClassificationIa	DiseaseMetabolic/genetic/	BrandViokace	CompanyAptalis Pharma US, Inc.	Physical AppearanceBeige-white amorphous powder, miscible in water and practically insoluble in alcohol and converted to tablet form	Route of AdministartionOral route	CategoryGastrointestinal Agents and Enzyme Replacement Agents	TargetSynaptosomal-associated protein 25,Rho-related GTP-binding protein RhoB, Dietary fat,Dietary protein,Dietary starch
ID1424	ThPPIDTh1071	NamePancrelipase	Peptide SequencePancreatic alpha amy Full view	Length1206	Functional ClassificationIa	DiseaseMetabolic/genetic/	BrandULTRESA	CompanyAptalis Pharma US, Inc.	Physical AppearanceBeige-white amorphous powder, miscible in water and practically insoluble or insoluble in alcohol and ether and converted to Delayed-Release Capsules	Route of AdministartionOral route	CategoryGastrointestinal Agents and Enzyme Replacement Agents	TargetSynaptosomal-associated protein 25,Rho-related GTP-binding protein RhoB, Dietary fat,Dietary protein,Dietary starch
ID1425	ThPPIDTh1071	NamePancrelipase	Peptide SequencePancreatic alpha amy Full view	Length1206	Functional ClassificationIa	DiseaseMetabolic/genetic/	BrandPERTZYE	CompanyDigestive care US, Inc.	Physical AppearanceBeige-white amorphous powder, miscible in water and practically insoluble or insoluble in alcohol and ether PERTZYE delayed-release capsule	Route of AdministartionOral route	CategoryGastrointestinal Agents and Enzyme Replacement Agents	TargetSynaptosomal-associated protein 25,Rho-related GTP-binding protein RhoB, Dietary fat,Dietary protein,Dietary starch
ID1426	ThPPIDTh1071	NamePancrelipase	Peptide SequencePancreatic alpha amy Full view	Length1206	Functional ClassificationIa	DiseaseMetabolic/genetic/	BrandULTRASE	CompanyAxcan Pharma	Physical AppearanceCapsules Enteric-Coated Microspheres	Route of AdministartionOral route	CategoryGastrointestinal Agents and Enzyme Replacement Agents	TargetSynaptosomal-associated protein 25,Rho-related GTP-binding protein RhoB, Dietary fat,Dietary protein,Dietary starch
ID1427	ThPPIDTh1071	NamePancrelipase	Peptide SequencePancreatic alpha amy Full view	Length1206	Functional ClassificationIa	DiseaseMetabolic/genetic/	BrandZENPEP	CompanyAptalis Pharma US, Inc.	Physical AppearanceDelayed-Release Capsules	Route of AdministartionOral route	CategoryGastrointestinal Agents and Enzyme Replacement Agents	TargetSynaptosomal-associated protein 25,Rho-related GTP-binding protein RhoB, Dietary fat,Dietary protein,Dietary starch
ID1470	ThPPIDTh1092	NameArcitumomab	Peptide SequenceHeavy chain 1EVKLVES Full view	Length1310	Functional ClassificationIIb	DiseaseCancer	BrandCEA-Scan	CompanyN.A.	Physical AppearanceN.A.	Route of AdministartionN.A.	CategoryDiagnostic Agents	TargetVascular endothelial growth factor A,Low affinity immunoglobulin gamma Fc region receptor III-B,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Low affinity immunoglobulin gamma Fc region receptor III-A,High affinity immunoglobulin gamma Fc receptor I,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor II-c, Carcinoembryonic antigen-related cell adhesion molecule 1
ID1477	ThPPIDTh1097	NameAlglucosidase Alfa	Peptide SequenceAHPGRPRAVPTQCDVPPNSR Full view	Length882	Functional ClassificationIc	DiseaseMetabolic	BrandLUMIZYME	CompanyGenzyme	Physical AppearanceSterile, nonpyrogenic, white to off-white, lyophilized cake or powder for reconstitution with 10.3 Ml Sterile Water for Injection, USP	Route of AdministartionIntravenous infusion	CategoryEnzyme Replacement Agents	TargetCation-dependent mannose-6-phosphate receptor,Glycogen
ID1533	ThPPIDTh1112	NameNatural Alpha Interferon Or Multiferon	Peptide SequenceInteferon alpha-1: Full view	Length997	Functional ClassificationIIa	DiseaseCancer/Infectious	BrandIntron/ Roferon-A	CompanyN.A.	Physical AppearanceN.A.	Route of AdministartionSubcutaneous injection, Intravenous injection, Intramuscular injection	CategoryN.A.	TargetN.A.
ID1537	ThPPIDTh1116	NameCanakinumab	Peptide SequenceH-GAMMA-1 (VH(1-118) Full view	Length842	Functional ClassificationIIIb	DiseaseImmunological	BrandILARISÂÂÂ	CompanyNovartis Pharmaceuticals	Physical AppearanceWhite, preservative-free, lyophilized powder	Route of AdministartionSubcutaneous injection	CategoryAnti-Inflammatory Agents and Monoclonal antibodies	TargetInterleukin-1 beta
ID1562	ThPPIDTh1122	NameRilonacept	Peptide Sequencerilonacept|Homo sapi Full view	Length880	Functional ClassificationIIa	DiseaseImmunological	BrandArcalyst	CompanyRegeneron Pharmaceuticals	Physical AppearanceSterile, white to off-white, lyophilized powder	Route of AdministartionSubcutaneous injection	CategoryImmunosuppressive Agents	TargetInterleukin-1 beta,Interleukin-1 alpha,Interleukin-1 receptor antagonist protein
ID1673	ThPPIDTh1160	NameSatumomab Pendetide	Peptide SequenceHeavy Chain 1: QVQLQ Full view	Length1299	Functional ClassificationIV	DiseaseDiagnostic Agents	BrandOncoScint	CompanyCytogen Corp, Lonza Biologics	Physical AppearanceN.A.	Route of AdministartionIntravenous Injection	CategoryDiagnostic Agents	TargetTumor-associated glycoprotein 72 (TAG-72)
ID1785	ThPPIDTh1190	NameImmune Globulin Human	Peptide SequenceIGG1: PSALTQPPSASGSL Full view	Length1338	Functional ClassificationIIIb	DiseaseImmunological Disorders	BrandBivigam	CompanyKedrion Biopharma, Inc.	Physical AppearanceInjection, Solution	Route of AdministartionIntravenous	CategoryImmunologic Factors; Immunosuppressive Agents; Anti-Infective Agents	TargetHigh affinity immunoglobulin gamma Fc receptor I; High affinity immunoglobulin gamma Fc receptor IB; Low affinity immunoglobulin gamma Fc region receptor II-a; Low affinity immunoglobulin gamma Fc region receptor II-b; Low affinity immunoglobulin gamma Fc region receptor II-c; Low affinity immunoglobulin gamma Fc region receptor III-A; Low affinity immunoglobulin gamma Fc region receptor III-B; Complement C3; Complement C4-A; Complement C4-B; Complement C5.
ID1786	ThPPIDTh1190	NameImmune Globulin Human	Peptide SequenceIGG1: PSALTQPPSASGSL Full view	Length1338	Functional ClassificationIIIb	DiseaseImmunological Disorders	BrandBivigam	CompanyBiotest Pharmaceuticals Corporation	Physical AppearanceInjection, Solution	Route of AdministartionIntravenous	CategoryImmunologic Factors; Immunosuppressive Agents; Anti-Infective Agents	TargetHigh affinity immunoglobulin gamma Fc receptor I; High affinity immunoglobulin gamma Fc receptor IB; Low affinity immunoglobulin gamma Fc region receptor II-a; Low affinity immunoglobulin gamma Fc region receptor II-b; Low affinity immunoglobulin gamma Fc region receptor II-c; Low affinity immunoglobulin gamma Fc region receptor III-A; Low affinity immunoglobulin gamma Fc region receptor III-B; Complement C3; Complement C4-A; Complement C4-B; Complement C5.
ID1788	ThPPIDTh1190	NameImmune Globulin Human	Peptide SequenceIGG1: PSALTQPPSASGSL Full view	Length1338	Functional ClassificationIIIb	DiseaseImmunological Disorders	BrandCarimune Nanofiltered	CompanyCsl Behring Ag	Physical AppearanceInjection, Powder, Lyophilized, for Solution	Route of AdministartionIntravenous	CategoryImmunologic Factors; Immunosuppressive Agents; Anti-Infective Agents	TargetHigh affinity immunoglobulin gamma Fc receptor I; High affinity immunoglobulin gamma Fc receptor IB; Low affinity immunoglobulin gamma Fc region receptor II-a; Low affinity immunoglobulin gamma Fc region receptor II-b; Low affinity immunoglobulin gamma Fc region receptor II-c; Low affinity immunoglobulin gamma Fc region receptor III-A; Low affinity immunoglobulin gamma Fc region receptor III-B; Complement C3; Complement C4-A; Complement C4-B; Complement C5.
ID1791	ThPPIDTh1190	NameImmune Globulin Human	Peptide SequenceIGG1: PSALTQPPSASGSL Full view	Length1338	Functional ClassificationIIIb	DiseaseImmunological Disorders	BrandFlebogamma Dif	CompanyGRIFOLS USA, LLC	Physical AppearanceInjection, Solution	Route of AdministartionIntravenous	CategoryImmunologic Factors; Immunosuppressive Agents; Anti-Infective Agents	TargetHigh affinity immunoglobulin gamma Fc receptor I; High affinity immunoglobulin gamma Fc receptor IB; Low affinity immunoglobulin gamma Fc region receptor II-a; Low affinity immunoglobulin gamma Fc region receptor II-b; Low affinity immunoglobulin gamma Fc region receptor II-c; Low affinity immunoglobulin gamma Fc region receptor III-A; Low affinity immunoglobulin gamma Fc region receptor III-B; Complement C3; Complement C4-A; Complement C4-B; Complement C5.
ID1793	ThPPIDTh1190	NameImmune Globulin Human	Peptide SequenceIGG1: PSALTQPPSASGSL Full view	Length1338	Functional ClassificationIIIb	DiseaseImmunological Disorders	BrandGamastan	CompanyCutter Med & Biol, Division Of Miles Canada Ltd.	Physical Appearanceliquid	Route of AdministartionIntramuscular	CategoryImmunologic Factors; Immunosuppressive Agents; Anti-Infective Agents	TargetHigh affinity immunoglobulin gamma Fc receptor I; High affinity immunoglobulin gamma Fc receptor IB; Low affinity immunoglobulin gamma Fc region receptor II-a; Low affinity immunoglobulin gamma Fc region receptor II-b; Low affinity immunoglobulin gamma Fc region receptor II-c; Low affinity immunoglobulin gamma Fc region receptor III-A; Low affinity immunoglobulin gamma Fc region receptor III-B; Complement C3; Complement C4-A; Complement C4-B; Complement C5.
ID1794	ThPPIDTh1190	NameImmune Globulin Human	Peptide SequenceIGG1: PSALTQPPSASGSL Full view	Length1338	Functional ClassificationIIIb	DiseaseImmunological Disorders	BrandGamastan S/d	CompanyGRIFOLS USA, LLC	Physical AppearanceInjection	Route of AdministartionIntramuscular	CategoryImmunologic Factors; Immunosuppressive Agents; Anti-Infective Agents	TargetHigh affinity immunoglobulin gamma Fc receptor I; High affinity immunoglobulin gamma Fc receptor IB; Low affinity immunoglobulin gamma Fc region receptor II-a; Low affinity immunoglobulin gamma Fc region receptor II-b; Low affinity immunoglobulin gamma Fc region receptor II-c; Low affinity immunoglobulin gamma Fc region receptor III-A; Low affinity immunoglobulin gamma Fc region receptor III-B; Complement C3; Complement C4-A; Complement C4-B; Complement C5.
ID1795	ThPPIDTh1190	NameImmune Globulin Human	Peptide SequenceIGG1: PSALTQPPSASGSL Full view	Length1338	Functional ClassificationIIIb	DiseaseImmunological Disorders	BrandHyqvia	CompanyBaxalta Us Inc.	Physical AppearanceLiquid	Route of AdministartionIntravenous infusion	CategoryImmunologic Factors; Immunosuppressive Agents; Anti-Infective Agents	TargetHigh affinity immunoglobulin gamma Fc receptor I; High affinity immunoglobulin gamma Fc receptor IB; Low affinity immunoglobulin gamma Fc region receptor II-a; Low affinity immunoglobulin gamma Fc region receptor II-b; Low affinity immunoglobulin gamma Fc region receptor II-c; Low affinity immunoglobulin gamma Fc region receptor III-A; Low affinity immunoglobulin gamma Fc region receptor III-B; Complement C3; Complement C4-A; Complement C4-B; Complement C5.
ID1796	ThPPIDTh1190	NameImmune Globulin Human	Peptide SequenceIGG1: PSALTQPPSASGSL Full view	Length1338	Functional ClassificationIIIb	DiseaseImmunological Disorders	BrandIveegam Immuno 5000mg (iv)	CompanyBaxter Ag	Physical AppearanceNA	Route of AdministartionNA	CategoryImmunologic Factors; Immunosuppressive Agents; Anti-Infective Agents	TargetHigh affinity immunoglobulin gamma Fc receptor I; High affinity immunoglobulin gamma Fc receptor IB; Low affinity immunoglobulin gamma Fc region receptor II-a; Low affinity immunoglobulin gamma Fc region receptor II-b; Low affinity immunoglobulin gamma Fc region receptor II-c; Low affinity immunoglobulin gamma Fc region receptor III-A; Low affinity immunoglobulin gamma Fc region receptor III-B; Complement C3; Complement C4-A; Complement C4-B; Complement C5.
ID1805	ThPPIDTh1199	NameRamucirumab	Peptide Sequenceramucirumab|Homo sap Full view	Length909	Functional ClassificationIIIc	DiseaseCancer	BrandCyramza	CompanyEli Lilly and Company	Physical AppearanceSolution	Route of AdministartionIntravenous	CategoryAntineoplastic and Immunomodulating Agents	TargetVascular endothelial growth factor receptor 2
ID1832	ThPPIDTh1222	NameCanakinumab	Peptide SequenceH-GAMMA-1 Chain: QVQ Full view	Length842	Functional ClassificationIIa	DiseaseImmunological Disorders	BrandIlaris	CompanyNovartis	Physical AppearanceLyphilized powder	Route of AdministartionSubcutaneous	CategoryAntineoplastic and Immunomodulating Agents	TargetInterleukin-1 beta
ID1851	ThPPIDTh1238	NameSusoctocog alfa	Peptide SequenceAIRRYYLGAVELSWDYRQSE Full view	Length1448	Functional ClassificationIb	DiseaseHematological Disorders	BrandObizur	CompanyNA	Physical AppearancePowder and solvent for solution for injection.	Route of AdministartionIntravenous	CategoryBlood coagulation factors, Antihaemorrhagics	Targetvon Willebrand factor